Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Incentives, Novel Tech Seen Driving Multiple Korean IPOs In 2018

Feb 07 2018

• By Jung Won Shin

Money Wave

Related Content

INTERVIEW: Bridge Chief On Pursuing NRDO, Global Ambitions

Aug 05 2016

Interview: Fledgling ABL Bio And Its Global Ambitions In Bispecific Antibodies

Aug 17 2017

Promising Tanibirumab Trial Boosts PharmAbcine’s Confidence

Sep 26 2016

After Record Series A, Eutilex Eyes T-Cell, Antibody Partnerships

Dec 23 2016

Spotlight On TissueGene’s Upcoming Korea IPO

Sep 06 2017

AbClon Shines On Korean Debut Amid Robust Investor Interest

Sep 20 2017

Interview: OliPass An Oligonucleotide Outsider With Big Ambitions

May 15 2017

SK Bio To Go All The Way With Novel Epilepsy Drug

Mar 18 2016

Celltrion Healthcare IPO To Accelerate Celltrion's Global Biosimilar Expansion

Jul 21 2017

OliX Eyes RNAi Leadership In Asia And Beyond

Jan 08 2018

Related Companies

Kolon TissueGene, Inc.

OliPass Corporation

PharmAbcine, Inc.

Bridge Biotherapeutics, Inc.

SK Biopharmaceuticals Co., Ltd

Jazz Pharmaceuticals plc

Additional Topics

South Korea Asia Pacific Commercial Financing BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window